10 Conclusions and clinical take-home messages 10.1 Main findings: certainties amidst uncertainties Synthesizing the current evidence, the information architecture regarding GLP-1RAs in PCOS fertility management exhibits a characteristic gradient: robust metabolic evidence, hypothesis-generating reproductive findings, and a gray zone of safety. Robust metabolic benefit: in overweight or obese PCOS phenotypes, evidence for the improvement of metabolic endpointsincluding body weight, central adiposity, and IRis consistently positive, facilitating the establishment of actionable therapeutic goals (e.g., reaching clinically significant weight-loss thresholds and optimizing IR markers)
Now, in my diet, I've been sticking to eating to the same things every single day
Tirzepatide users with baseline glucose dysregulation should discuss alcohol consumption with their prescribing provider before drinking
Common side effects normally go away on their own within a few days or up to 2-3 weeks
J., Bergenstal, R., Bode, B
, , , , ,
